We do not condone these practices and its important to understand that for Ozempic, only the marked doses on the pens (0.25, 0.5, 1.0 and 2.0 mg) are approved for use (with 0.25 mg only approved for initiation and not maintenance), a Novo Nordisk spokesperson said in an email
Common scenarios include: Sitting on a pharmacy counter during processing Transport from pharmacy to home without insulation Power outage affecting your refrigerator Accidental placement in a freezer compartment Leaving the pen out after an injection Travel without proper cooling Each temperature excursion accumulates
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus, administered as a once-weekly subcutaneous injection
Together, we can support our friends, family and co-workers and uplift our communities.
Current MHRA guidance is clear that Ozempic should be prescribed only for type 2 diabetes, partly to protect supply for patients living with diabetes
